Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
MetadataShow full item record
The present invention provides MSCRAMM® proteins from S. aureus which are putative highly-expressed antigens from methicillin-resistant S. aureus, including communit-associated MRSA (CA-MRSA), and these antigens can thus be utilized in methods of generating antibodies capable of binding these antigens which can be useful in methods of treating or preventing infection from MRSA. The present invention is directed to these proteins, antibodies capable of binding these proteins, methods of generating said antibodies, nucleic acids coding for said proteins, and pharmaceutical compositions or vaccines which include the proteins or antibodies of the present invention in combination with a pharmaceutically acceptable vehicle, carrier or excipient.
Hook, Magnus; Labandeira-rey, Maria; Bowden, Gabriela M. (2012). Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from